Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Multiple Myeloma 11 Lymphoma, Non-Hodgkin 9 Lymphoma 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Leukemia, Myeloid, Acute 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Hodgkin Disease 5 Myelodysplastic Syndromes 4 Neoplasms, Plasma Cell 3 Melanoma 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia 3 Glioma 3 Carcinoma, Non-Small-Cell Lung 3 Primary Myelofibrosis 2 Ovarian Neoplasms 2 Myeloproliferative Disorders 2 Lymphoma, B-Cell 2 Immunoglobulin Light-chain Amyloidosis 2 Hematologic Neoplasms 2 Glioblastoma 2 Burkitt Lymphoma 2 Wilms Tumor 1 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Sarcoma 1 Recurrence 1 Philadelphia Chromosome 1 Pancreatic Neoplasms 1 Osteosarcoma 1

Interventions

pembrolizumab 14 Injections 13 Paclitaxel 10 Nivolumab 10 Docetaxel 9 Cisplatin 9 Capecitabine 9 Bevacizumab 8 toripalimab 7 senaparib 7 Fluorodeoxyglucose F18 7 Cyclophosphamide 7 tislelizumab 6 atezolizumab 6 Irinotecan 6 Fluorouracil 6 Gemcitabine 5 fludarabine 4 apatinib 4 Oxaliplatin 4 Leucovorin 4 Ipilimumab 4 Carboplatin 4 spartalizumab 3 sintilimab 3 pertuzumab 3 olaparib 3 camrelizumab 3 Rifampin 3 Radiosurgery 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor × Blood Component Removal × Clear all

NCT07137312 2025-12-23

Ex Vivo Expansion (ACT-X)

Mayo Clinic

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡